Literature DB >> 1879948

Successive synovial Mycoplasma hominis isolates exhibit apparent antigenic variation.

L D Olson1, C A Renshaw, S W Shane, M F Barile.   

Abstract

The expression of surface proteins by 14 successive Mycoplasma hominis isolates obtained from the synovial fluid of a chronically infected septic arthritis patient was examined. Marked differences in the expression of surface proteins, as determined by monoclonal antibodies raised against the first isolate, were observed. However, identical restriction patterns and virtually identical hybridization patterns with probes containing the conserved genes of the Mycoplasma capricolum rRNA operon and the Escherichia coli elongation factor Tu suggest that the protein differences might reflect antigenic variation by M. hominis during infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879948      PMCID: PMC258176          DOI: 10.1128/iai.59.9.3327-3329.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Genomic and gene variation in Mycoplasma hominis strains.

Authors:  G Christiansen; H Andersen; S Birkelund; E A Freundt
Journal:  Isr J Med Sci       Date:  1987-06

2.  Serologic typing of human genital T-mycoplasmas by a complement-dependent mycoplasmacidal test.

Authors:  J S Lin; M I Kendrick; E H Kass
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Prosthetic joint infection with Mycoplasma hominis.

Authors:  M Sneller; F Wellborne; M F Barile; P Plotz
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

5.  Combined type-specific antisera in the identification of Mycoplasma hominis.

Authors:  J S Lin; S Alpert; K M Radnay
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

6.  Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain.

Authors:  L D Olson; S W Shane; A A Karpas; T M Cunningham; P S Probst; M F Barile
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Ribosomal RNA genes in Mycoplasma.

Authors:  D Amikam; S Razin; G Glaser
Journal:  Nucleic Acids Res       Date:  1982-07-24       Impact factor: 16.971

Review 8.  Mycoplasma hominis- tissue cell interactions: a review with new observations on phenotypic and genotypic properties.

Authors:  M F Barile; M W Grabowski; E B Stephens; S J O'Brien; J M Simonson; K Izumikawa; D K Chandler; D Taylor-Robinson; J G Tully
Journal:  Sex Transm Dis       Date:  1983 Oct-Dec       Impact factor: 2.830

9.  Serological reactions of Mycoplasma hominis: differences among mycoplasmacidal, metabolic inhibition, and growth agglutination tests.

Authors:  J S Lin; E H Kass
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

10.  Analysis of the mycoplasma genome by recombinant DNA technology.

Authors:  C Christiansen; J Frydenberg; G Christiansen; H Andersen; L Hedegaard
Journal:  Isr J Med Sci       Date:  1984-09
View more
  10 in total

1.  Molecular basis of size and antigenic variation of a Mycoplasma hominis adhesin encoded by divergent vaa genes.

Authors:  Q Zhang; K S Wise
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552.

Authors:  L T Jensen; S Ladefoged; S Birkelund; G Christiansen
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  An Excision-Competent and Exogenous Mosaic Transposon Harbors the tetM Gene in Multiple Mycoplasma hominis Lineages.

Authors:  Michael J Calcutt; Mark F Foecking
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

4.  Detection of antibodies to a pathogenic mycoplasma in American alligators (Alligator mississippiensis), broad-nosed Caimans (Caiman latirostris), and Siamese crocodiles (Crocodylus siamensis).

Authors:  D R Brown; I M Schumacher; M F Nogueira; L J Richey; L A Zacher; T R Schoeb; K A Vliet; R A Bennett; E R Jacobson; M B Brown
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans.

Authors:  P M Theiss; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Identification of serotype 1-, 3-, and 6-specific antigens of Ureaplasma urealyticum by using monoclonal antibodies.

Authors:  X Cheng; A Naessens; S Lauwers
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Antigen heterogeneity among isolates of Mycoplasma bovis is generated by high-frequency variation of diverse membrane surface proteins.

Authors:  R Rosengarten; A Behrens; A Stetefeld; M Heller; M Ahrens; K Sachse; D Yogev; H Kirchhoff
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

9.  Thymidine utilisation pathway is a novel phenotypic switch of Mycoplasma hominis.

Authors:  Gleb Yu Fisunov; Olga V Pobeguts; Valentina G Ladygina; Alexandr I Zubov; Mariya A Galyamina; Sergey I Kovalchuk; Rustam K Ziganshin; Daria V Evsyutina; Daria S Matyushkina; Ivan O Butenko; Olga N Bukato; Vladimir A Veselovsky; Tatiana A Semashko; Ksenia M Klimina; Galina A Levina; Olga I Barhatova; Irina V Rakovskaya
Journal:  J Med Microbiol       Date:  2022-01       Impact factor: 2.472

10.  The vaa locus of Mycoplasma hominis contains a divergent genetic islet encoding a putative membrane protein.

Authors:  Thomas Boesen; Jeppe Emmersen; Agata Baczynska; Svend Birkelund; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2004-09-22       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.